Nanobiotix receives first tranche disbursement of 16 million euros financing from European Investment Bank
16 oct. 2018 02h13 HE
|
NANOBIOTIX
Nanobiotix receives first tranche disbursement of 16 million euros financing from European Investment Bank Proceeds will be used to speed up development of pioneering lead product NBTXR3 and to...
CNS Drugs Take 20% Longer to Develop and 38% Longer to Approve vs. Non-CNS Drugs, According to the Tufts Center for the Study of Drug Development
11 sept. 2018 09h00 HE
|
Tufts Center for the Study of Drug Development
BOSTON, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Developing drugs to treat central nervous system (CNS) disorders on average required 20% more time than other drugs that won marketing approval in the...
Satellite Launch Vehicle (SLV) Market worth $2.4bn by 2024: Global Market Insights, Inc.
29 août 2018 07h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Aug. 29, 2018 (GLOBE NEWSWIRE) -- Satellite Launch Vehicle (SLV) Market is set to surpass USD 2.4 billion by 2024; according to a new research report by Global Market...
CINDE announces: Hewlett Packard Enterprise Will Hire 120 More Workers for Supply Chain and R&D in Costa Rica
27 août 2018 15h08 HE
|
CINDE
Heredia, Costa Rica, Aug. 27, 2018 (GLOBE NEWSWIRE) -- Hewlett Packard Enterprise (HPE) continues its expansion in Costa Rica. Today, the company celebrated the grand opening of its new offices...
3D Printing in Automotive Market to cross $8bn by 2024: Global Market Insights, Inc.
27 août 2018 07h00 HE
|
Global Market Insights, Inc
Sellbyville, Delaware, Aug. 27, 2018 (GLOBE NEWSWIRE) -- 3D Printing in Automotive Market is expected to exceed USD 8 billion by 2024; according to a new research report by Global Market...
Rising Protocol Complexity Is Hindering Performance while Driving Up Cost of Clinical Trials, According to the Tufts Center for the Study of Drug Development
17 juil. 2018 09h00 HE
|
Tufts Center for the Study of Drug Development
BOSTON, July 17, 2018 (GLOBE NEWSWIRE) -- Rising protocol complexity is hindering clinical trial performance and efficiency, and helping to drive up the cost of developing new drugs, according to a...
Constellium expands R&D capabilities at Brunel University London
13 juin 2018 04h00 HE
|
Constellium Paris
AMSTERDAM, The Netherlands, June 13, 2018 (GLOBE NEWSWIRE) -- Constellium N.V. (NYSE:CSTM) announced today that it has expanded the capability of its University Technology Center (UTC) at Brunel...
Global Challengers Lead Digital Business Revolution
17 mai 2018 20h00 HE
|
BCG
BOSTON, May 17, 2018 (GLOBE NEWSWIRE) -- In its 9th report since 2006 on the leading companies in emerging markets, Global Challengers 2018: Digital Leapfrogs, which is being released today, The...
Exosome Diagnostics Presents Breakthrough Data Highlighting Tumor Derived RNA in Biofluids at the International Society for Extracellular Vesicles in Spain
15 mai 2018 09h52 HE
|
Exosome Diagnostics
Waltham, MA, May 15, 2018 (GLOBE NEWSWIRE) -- Exosome Diagnostics, Inc. received great interest from their presentations at the International Society for Extracellular Vesicles (ISEV) 2018 in...
Patent-to-Launch Time for Orphan Drugs is 2.3 Years Longer vs. Other Drugs, According to the Tufts Center for the Study of Drug Development
09 mai 2018 09h00 HE
|
Tufts Center for the Study of Drug Development
BOSTON, May 09, 2018 (GLOBE NEWSWIRE) -- Orphan drug development, which faces special challenges in recruiting sufficient numbers of patients for clinical trials, on average takes 15.1 years to go...